Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
2014 · PROTEOMICS - CLINICAL APPLICATIONS · 468 citations
https://doi.org/10.1002/prca.201300095
M
Mark D. Gorrell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
213
Papers
8.7K
Citations
50
h-index
123
i10-index
Mark D. Gorrell is an academic researcher from University of Sydney. The author has contributed to research in topics: Peptidase Inhibition and Analysis & Neuropeptides and Animal Physiology & Liver Disease Diagnosis and Treatment. The author has an h-index of 50, co-authored 182 publications.
ORCID: 0000-0002-0528-2604Papers by this author
worksThe challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
2009 · Liver International · 64 citations
https://doi.org/10.1111/j.1478-3231.2010.02264.x
Kynurenine Aminotransferases and the Prospects of Inhibitors for the Treatment of Schizophrenia
2015 · Current Medicinal Chemistry · 40 citations
https://doi.org/10.2174/0929867322666150608094054
The hepatic transcriptome in human liver disease
2006 · Comparative Hepatology · 34 citations
https://doi.org/10.1186/1476-5926-5-6
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis
2024 · Journal of Translational Medicine · 23 citations
https://doi.org/10.1186/s12967-023-04830-z
Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5839233
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat